-+ 0.00%
-+ 0.00%
-+ 0.00%

Pliant Therapeutics Q2 EPS $(0.71), Inline

Benzinga·08/07/2025 20:56:57
Listen to the news
Pliant Therapeutics (NASDAQ:PLRX) reported quarterly losses of $(0.71) per share which met the analyst consensus estimate. This is a 22.83 percent increase over losses of $(0.92) per share from the same period last year.